Insider · CIK 0001600253

Crotty Robert

Reports to the SEC for 3 companies · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001600253

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-08-31	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−37 sh	$1.06	−$39.22	41,194
2021-08-06	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−74 sh	$1.17	−$86.58	41,231
2021-07-31	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−37 sh	$1.10	−$40.7	41,305
2021-07-06	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−74 sh	$1.27	−$93.98	41,342
2021-06-30	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−37 sh	$1.35	−$49.95	41,416
2021-06-06	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−73 sh	$1.34	−$97.82	41,453
2021-05-31	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−37 sh	$1.38	−$51.06	41,526
2021-05-06	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−74 sh	$1.49	−$110.26	41,563
2021-04-30	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−37 sh	$1.78	−$65.86	41,637
2021-04-06	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−74 sh	$1.73	−$128.02	41,674
2021-03-31	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−37 sh	$1.66	−$61.42	42,689
2021-03-06	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−71 sh	$1.79	−$127.09	41,748
2021-02-28	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−38 sh	$2.39	−$90.82	42,726
2021-02-06	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−870 sh	$2.90	−$2,523	41,819
2021-01-31	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−43 sh	$2.62	−$112.66	42,764
2021-01-29	Nabriva Therapeutics plcA Award	Gen Counsel & Corp Secretary	AAward	+22.5K sh	—	—	42,807
2020-12-31	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−37 sh	$2.42	−$89.54	20,307
2020-11-30	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−368 sh	$0.43	−$157.136	203,444
2020-10-31	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−366 sh	$0.50	−$181.353	203,812
2020-09-30	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−366 sh	$0.53	−$195.078	204,178
2020-08-31	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−366 sh	$0.62	−$226.7	204,544
2020-08-20	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−3,759 sh	$0.65	−$2,434.328	204,910
2020-08-19	Nabriva Therapeutics plcM Exercise/Conversion	Gen Counsel & Corp Secretary	MExercise/Conversion	+11.3K sh	—	—	208,669
2020-08-19	Nabriva Therapeutics plcRestricted Share UnitsM Exercise/Conversion	Gen Counsel & Corp Secretary	MExercise/Conversion	−11.3K sh	—	—	0
2020-07-31	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−366 sh	$0.76	−$278.16	197,419
2020-06-30	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−366 sh	$0.67	−$246.904	197,785
2020-05-31	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−366 sh	$1.14	−$417.24	198,151
2020-04-30	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−366 sh	$0.55	−$200.678	198,517
2020-03-31	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−366 sh	$0.57	−$210.45	198,883
2020-02-28	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−366 sh	$1.35	−$494.1	199,276
2020-02-06	Nabriva Therapeutics plcA Award	Gen Counsel & Corp Secretary	AAward	+105K sh	—	—	188,097
2020-02-06	Nabriva Therapeutics plcStock OptionsA Award	Gen Counsel & Corp Secretary	AAward	+210K sh	—	—	210,000
2020-01-31	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−3,892 sh	$1.35	−$5,254.2	83,097
2019-08-21	Nabriva Therapeutics plcF Tax Payment	Gen Counsel & Corp Secretary	FTax Payment	−3,797 sh	$2.08	−$7,897.76	23,239
2019-08-21	Nabriva Therapeutics plcS Sale	Gen Counsel & Corp Secretary	SSale	−3,797 sh	$2.08	−$7,897.76	23,239
2019-08-19	Nabriva Therapeutics plcM Exercise/Conversion	Gen Counsel & Corp Secretary	MExercise/Conversion	+11.3K sh	—	—	27,036
2019-08-19	Nabriva Therapeutics plcRestricted Share UnitsM Exercise/Conversion	Gen Counsel & Corp Secretary	MExercise/Conversion	−11.3K sh	—	—	11,250
2019-01-31	Nabriva Therapeutics plcRestricted Stock UnitsA Award	Gen Counsel & Corp Secretary	AAward	+52.5K sh	—	—	52,500
2019-01-31	Nabriva Therapeutics plcStock OptionsA Award	Gen Counsel & Corp Secretary	AAward	+138K sh	—	—	138,200
2018-05-23	Nabriva Therapeutics plcP Purchase	Gen Counsel & Corp Secretary	PPurchase	+10K sh	$4.48	+$44.8K	10,000
2018-01-31	Nabriva Therapeutics plcStock OptionsA Award	Gen Counsel & Corp Secretary	AAward	+100K sh	—	—	100,000
2018-01-31	Nabriva Therapeutics plcRestricted Stock UnitsA Award	Gen Counsel & Corp Secretary	AAward	+22.5K sh	—	—	22,500
2017-06-30	Nabriva Therapeutics Legacy plcStock OptionA Award	General Counsel & Corp Secreta	AAward	+90K sh	—	—	90,000
2015-02-17	DENDREON CORPS Sale	EVP, General Counsel	SSale	−21.8K sh	$0.08	−$1,765.06	97,855
2015-01-31	DENDREON CORPF Tax Payment	EVP, General Counsel	FTax Payment	−470 sh	$0.16	−$75.2	119,619
2014-11-30	DENDREON CORPF Tax Payment	EVP, General Counsel	FTax Payment	−912 sh	$0.14	−$125.856	120,089
2014-10-31	DENDREON CORPF Tax Payment	EVP, General Counsel	FTax Payment	−472 sh	$0.98	−$462.324	121,001
2014-08-31	DENDREON CORPF Tax Payment	EVP, General Counsel	FTax Payment	−912 sh	$1.36	−$1,240.32	121,473
2014-07-31	DENDREON CORPF Tax Payment	EVP, General Counsel	FTax Payment	−472 sh	$2.07	−$977.04	122,385
2014-02-28	DENDREON CORPA Award	EVP, General Counsel	AAward	+60K sh	—	—	128,183

Recent filings

Accepted (ET)
Sep 24
Crotty Robert0001104659-21-112476
SEC(opens sec.gov)
Aug 104
Crotty Robert0001104659-21-102949
SEC(opens sec.gov)
Aug 34
Crotty Robert0001104659-21-099443
SEC(opens sec.gov)
Jul 84
Crotty Robert0001104659-21-090212
SEC(opens sec.gov)
Jul 24
Crotty Robert0001104659-21-088844
SEC(opens sec.gov)
Jun 84
Crotty Robert0001104659-21-078216
SEC(opens sec.gov)
Jun 24
Crotty Robert0001104659-21-075734
SEC(opens sec.gov)
May 104
Crotty Robert0001104659-21-064052
SEC(opens sec.gov)
May 44
Crotty Robert0001104659-21-060954
SEC(opens sec.gov)
Apr 84
Crotty Robert0001104659-21-048253
SEC(opens sec.gov)
Apr 24
Crotty Robert0001104659-21-046194
SEC(opens sec.gov)
Mar 24
Crotty Robert0001104659-21-030944
SEC(opens sec.gov)
Feb 24
Crotty Robert0001104659-21-011112
SEC(opens sec.gov)
Jan 54
Crotty Robert0001104659-21-001027
SEC(opens sec.gov)
Dec 14
Crotty Robert0001104659-20-131219
SEC(opens sec.gov)
Nov 24
Crotty Robert0001104659-20-120638
SEC(opens sec.gov)
Oct 14
Crotty Robert0001104659-20-111074
SEC(opens sec.gov)

Companies

Address

1301 2ND AVE

SEATTLE, WA, 98101